Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition
- 28 November 2011
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 108 (52), E1475-E1483
- https://doi.org/10.1073/pnas.1117988108
Abstract
There are currently few treatment options for pulmonary fibrosis. Innovations may come from a better understanding of the cellular origin of the characteristic fibrotic lesions. We have analyzed normal and fibrotic mouse and human lungs by confocal microscopy to define stromal cell populations with respect to several commonly used markers. In both species, we observed unexpected heterogeneity of stromal cells. These include numerous cells with molecular and morphological characteristics of pericytes, implicated as a source of myofibroblasts in other fibrotic tissues. We used mouse genetic tools to follow the fates of specific cell types in the bleomcyin-induced model of pulmonary fibrosis. Using inducible transgenic alleles to lineage trace pericyte-like cells in the alveolar interstitium, we show that this population proliferates in fibrotic regions. However, neither these cells nor their descendants express high levels of the myofibroblast marker alpha smooth muscle actin (Acta2, aSMA). We then used a Surfactant protein C-CreERT2 knock-in allele to follow the fate of Type II alveolar cells (AEC2) in vivo. We find no evidence at the cellular or molecular level for epithelial to mesenchymal transition of labeled cells into myofibroblasts. Rather, bleomycin accelerates the previously reported conversion of AEC2 into AEC1 cells. Similarly, epithelial cells labeled with our Scgb1a1-CreER allele do not give rise to fibroblasts but generate both AEC2 and AEC1 cells in response to bleomycin-induced lung injury. Taken together, our results show a previously unappreciated heterogeneity of cell types proliferating in fibrotic lesions and exclude pericytes and two epithelial cell populations as the origin of myofibroblasts.This publication has 50 references indexed in Scilit:
- Alveolar Epithelial Cells Undergo Epithelial-to-Mesenchymal Transition in Response to Endoplasmic Reticulum StressOnline Journal of Public Health Informatics, 2011
- Progress Toward Improving Animal Models for Idiopathic Pulmonary FibrosisThe American Journal of the Medical Sciences, 2011
- Scraping fibrosis: Expressway to the core of fibrosisNature Medicine, 2011
- N-acetylcysteine inhibits alveolar epithelial-mesenchymal transitionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Autoimmune pancreatitis results from loss of TGF signalling in S100A4-positive dendritic cellsGut, 2009
- The Role of Scgb1a1+ Clara Cells in the Long-Term Maintenance and Repair of Lung Airway, but Not Alveolar, EpitheliumCell Stem Cell, 2009
- Role of platelet-derived growth factors in physiology and medicineGenes & Development, 2008
- Cellular and molecular mechanisms of fibrosisThe Journal of Pathology, 2007
- Lung development and repair: Contribution of the ciliated lineageProceedings of the National Academy of Sciences of the United States of America, 2007
- Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrixProceedings of the National Academy of Sciences of the United States of America, 2006